These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 79604)
1. Cytotoxic T lymphocytes to murine plasmacytoma cells in allogeneic and syngeneic mice: H-2 antigens are essential in the induction and effector stages of CTL. Kaneko Y; Natsuume-Sakai S; Migita S J Immunol; 1978 Aug; 121(2):427-37. PubMed ID: 79604 [No Abstract] [Full Text] [Related]
2. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids. Toffaletti DL; Darrow TL; Scott DW J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910 [TBL] [Abstract][Full Text] [Related]
3. [Origin of effector and rosette-forming cells in transplantation immunity in mice]. Brondz BD; Kotomina IF Biull Eksp Biol Med; 1973 Sep; 76(9):69-72. PubMed ID: 4130411 [No Abstract] [Full Text] [Related]
4. Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. I. Changes in reactivity with cytotoxic T lymphocytes and anti-H-2d sera. Celis E; Hale AH; Russell JH; Eisen HN J Immunol; 1979 Mar; 122(3):954-8. PubMed ID: 312828 [TBL] [Abstract][Full Text] [Related]
5. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens. Burton RC; Chism SE; Warner NL J Immunol; 1977 Mar; 118(3):971-80. PubMed ID: 300394 [TBL] [Abstract][Full Text] [Related]
6. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro. Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374 [TBL] [Abstract][Full Text] [Related]
7. The requirement of Ia-positive accessory cells for the induction of hapten-reactive cytotoxic T lymphocytes in vitro. Yamashita U; Hamaoka T J Immunol; 1979 Dec; 123(6):2637-43. PubMed ID: 315427 [No Abstract] [Full Text] [Related]
8. Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes. Hale AH; Paulus LK Eur J Immunol; 1979 Aug; 9(8):640-6. PubMed ID: 227696 [No Abstract] [Full Text] [Related]
9. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level. Sensi M; Orosz CG; Bach FH J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778 [TBL] [Abstract][Full Text] [Related]
10. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity. Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091 [TBL] [Abstract][Full Text] [Related]
11. Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens. Giorgi JV; Warner NL J Immunol; 1981 Jan; 126(1):322-30. PubMed ID: 6161166 [TBL] [Abstract][Full Text] [Related]
12. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier. Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457 [TBL] [Abstract][Full Text] [Related]
13. The biologic effects of allogeneic factor on T lymphocytes. II. The specificity of AEF-induced cytotoxic T lymphocytes. Altman A; Cardenas JM; Bechtold TE; Katz DH J Immunol; 1980 Jan; 124(1):114-20. PubMed ID: 6153087 [No Abstract] [Full Text] [Related]
14. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state. Weinhold KJ; Wheelock EF Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603 [TBL] [Abstract][Full Text] [Related]
15. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation. Claesson MH; Miller RG J Immunol; 1985 Feb; 134(2):684-90. PubMed ID: 2578160 [TBL] [Abstract][Full Text] [Related]
16. [Detection of a specific differentiation antigen of mouse T-cells activated by allogenic transplantation antigens]. Nesterenko VG; Gruner ShG Biull Eksp Biol Med; 1980 Jun; 89(6):708-10. PubMed ID: 6967339 [TBL] [Abstract][Full Text] [Related]
17. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis. Haubeck HD; Kölsch E Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340 [TBL] [Abstract][Full Text] [Related]
18. The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes. Fujiwara H; Hamaoka T; Shearer GM; Yamamoto H; Terry WD J Immunol; 1980 Feb; 124(2):863-9. PubMed ID: 6965392 [No Abstract] [Full Text] [Related]
19. Antibody-forming cells with specificity for syngeneic and allogeneic (thymocyte) tissue antigens following lipopolysaccharide mitogenic stimulation. McHugh YH; Bonavida B Transplant Proc; 1977 Mar; 9(1):1205-9. PubMed ID: 68566 [No Abstract] [Full Text] [Related]
20. Studies on the induction and expression of T cell-mediated immunity. IX. Activation of alloimmune memory lymphocytes into specific secondary CTL by syngeneic NAGO-oxidized stimulator cells. Grimm EA; Bonavida B J Immunol; 1979 Nov; 123(5):2026-33. PubMed ID: 314955 [No Abstract] [Full Text] [Related] [Next] [New Search]